Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (7116)
All Articles published online
|
Publishing Process of This Article
|
Mar 14, 2019 (publication date) through Nov 29, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Zhang Z, Dai DQ. MicroRNA-596 acts as a tumor suppressor in gastric cancer and is upregulated by promotor demethylation. World J Gastroenterol 2019; 25(10): 1224-1237 [PMID: 30886505 DOI: 10.3748/wjg.v25.i10.1224] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v25/i10/1224.htm |
| Number | Citing Articles |
| 1 |
Ligong Fu, Huawei Liu, Weijun Lei. MiR-596 inhibits osteoblastic differentiation and cell proliferation by targeting Smad3 in steroid-induced osteonecrosis of femoral head. Journal of Orthopaedic Surgery and Research 2020; 15(1) doi: 10.1186/s13018-020-01688-5
|
| 2 |
Yang Huang, Zuo-Gang Wang, Liang Tang, Su-Gang Gong, Yuan-Yuan Sun, Lan Wang, Rong Jiang, Wen-Hui Wu, Ci-Jun Luo, Jie Zhang, Xiao-Jun Yang, Jin-Ling Li, Xun-Tao Yuan, Qin-Hua Zhao, Ping Yuan. Plasma exosomal miR-596: a novel biomarker predicts survival in patients with idiopathic pulmonary artery hypertension. Journal of International Medical Research 2021; 49(3) doi: 10.1177/03000605211002379
|
| 3 |
Jie Zhang, Keqing Shi, Weiguo Huang, Wanqing Weng, Zhongjing Zhang, Yangyang Guo, Tuo Deng, Yukai Xiang, Xiaofeng Ni, Bicheng Chen, Mengtao Zhou. The DNA methylation profile of non-coding RNAs improves prognosis prediction for pancreatic adenocarcinoma. Cancer Cell International 2019; 19(1) doi: 10.1186/s12935-019-0828-8
|
| 4 |
J. Dai, G. Yuan, Y. Li, H. Zhou. MicroRNA-596 is epigenetically inactivated and suppresses prostatic cancer cell growth and migration via regulating Wnt/β-catenin signaling. Clinical and Translational Oncology 2021; 23(7): 1394 doi: 10.1007/s12094-020-02536-y
|
| 5 |
Chun-hui Lai, Xu-zhi Liang, Xiu-yun Liang, Sheng-jun Ma, Jun-guo Li, Ming-fang Shi, Xu Zhu, Hui-hua Lan, Jiang-hui Zeng. Study on miRNAs in Pan-Cancer of the Digestive Tract Based on the Illumina HiSeq System Data Sequencing. BioMed Research International 2019; 2019: 1 doi: 10.1155/2019/8016120
|
| 6 |
Hu Fen, Zheng Hongmin, Wei Wei, Yang Chao, Yao Yang, Liu Bei, Sun Zhihua. RHPN1-AS1 Drives the Progression of Hepatocellular Carcinoma via Regulating miR-596/IGF2BP2 Axis. Current Pharmaceutical Design 2020; 25(43): 4630 doi: 10.2174/1381612825666191105104549
|
| 7 |
Zhen Zhang, Dong-Qiu Dai. Correction to “MicroRNA-596 acts as a tumor suppressor in gastric cancer and is upregulated by promotor demethylation”. World Journal of Gastroenterology 2022; 28(43): 6203-6205 doi: 10.3748/wjg.v28.i43.6203
|
| 8 |
Sylwia Ciesielska, Izabella Slezak-Prochazka, Patryk Bil, Joanna Rzeszowska-Wolny. Micro RNAs in Regulation of Cellular Redox Homeostasis. International Journal of Molecular Sciences 2021; 22(11): 6022 doi: 10.3390/ijms22116022
|
| 9 |
Bashdar Mahmud Hussen, Hazha Jamal Hidayat, Abbas Salihi, Dana K. Sabir, Mohammad Taheri, Soudeh Ghafouri-Fard. MicroRNA: A signature for cancer progression. Biomedicine & Pharmacotherapy 2021; 138: 111528 doi: 10.1016/j.biopha.2021.111528
|
| 10 |
Jonathan K. L. Mak, Asmus Cosmos Skovgaard, Marianne Nygaard, Laura Kananen, Chandra A. Reynolds, Yunzhang Wang, Ralf Kuja‐Halkola, Ida K. Karlsson, Nancy L. Pedersen, Sara Hägg, Mette Soerensen, Juulia Jylhävä. Epigenome‐wide analysis of frailty: Results from two European twin cohorts. Aging Cell 2024; 23(6) doi: 10.1111/acel.14135
|
| 11 |
Deying Wang, Yulan Cui, Aili Xu, Lin Zhao, Peiling Li. MiR-596 activated by EP300 controls the tumorigenesis in epithelial ovarian cancer by declining BRD4 and KPNA4. Cancer Cell International 2020; 20(1) doi: 10.1186/s12935-020-01497-0
|
| 12 |
Yuxin He, Liangjian Zheng, Mengzhen Yuan, Jia Fan, Liwen Rong, Tingting Zhan, Jun Zhang. Exosomal circPRRX1 functions as a ceRNA for miR-596 to promote the proliferation, migration, invasion, and reduce radiation sensitivity of gastric cancer cells via the upregulation of NF-κB activating protein. Anti-Cancer Drugs 2022; 33(10): 1114 doi: 10.1097/CAD.0000000000001358
|
| 13 |
Xiwu Zhao, Jian Li, Dapeng Yu. MicroRNA-939-5p directly targets IGF-1R to inhibit the aggressive phenotypes of osteosarcoma through deactivating the PI3K/Akt pathway. International Journal of Molecular Medicine 2019; doi: 10.3892/ijmm.2019.4333
|